Latest Uveal melanoma Stories
Celebrities and Golf Enthusiasts Round Up Against Melanoma HOLLYWOOD, Calif., Oct.
- Median overall survival is encouraging for this patient population - BOULDER, Colo., Sept.
Statement from Tim Turnham, Executive Director, Melanoma Research Foundation WASHINGTON, Sept.
WASHINGTON, July 29, 2014 /PRNewswire-USNewswire/ -- Despite the epidemic rise in melanoma incidence and the increasingly heavy toll it is taking on young adults, this cancer has remained low on the
Leading Nonprofits in Melanoma Applaud Allocation of New Funds, Pledge to Advance Breakthrough Melanoma Treatments WASHINGTON, July 17, 2014 /PRNewswire-USNewswire/ -- Today the Senate
In patients with advanced uveal melanoma, treatment with the agent selumetinib, compared with chemotherapy, resulted in an improved cancer progression-free survival time and tumor response rate, but no improvement in overall survival.
Six Phase 3 / Pivotal Trials with Array's MEK Inhibitors Advancing BOULDER, Colo., June 2, 2014 /PRNewswire/ -- Two Array BioPharma-invented MEK inhibitors, binimetinib (MEK162) and
Melanoma Research Foundation presents Humanitarian Award. San Francisco, CA (PRWEB) May 23, 2014 Mohammed Kashani-Sabet, M.D., a physician with Sutter
BOULDER, Colo., May 14, 2014 /PRNewswire/ -- Array BioPharma Inc.
- To fire mitraille at.